Gusto Global

Gusto Global Stands at the Forefront of Microbiome Innovation, Leveraging New Sequencing and Computational Technologies to Deeply Understand the Impact of Microorganisms on Human Health. With Over 60 Years of Collective Experience in Microbiology, Molecular Biology, and Bacterial Behavior Modeling, Gusto’s Team Goes Beyond Traditional Understanding. Gusto’s Tapestry® Platform Integrates Mechanistic Interactions Between Microorganisms and Humans into Clinical Applications, Which Will Fundamentally Transform Healthcare. The Company’s Current Projects Target Immune-Mediated Diseases and Oncology. Gusto’s Mission Is to Detect and Provide Optimal Treatment Strategies and Outcomes for Diseases Influenced or Already Impacted by the Human Microbiome.